Table 1.
Demographic and clinical characteristics of patients
| Characteristic | Total (n= 1170) | Intervention (n= 588) | Control (n= 582) |
|---|---|---|---|
| Age in years, mean (SD) | 61 (6.4) | 61 (6.5) | 61 (6.3) |
|
| |||
| Educational level, n (%) | |||
| Primary | 456 (39.0) | 226 (38.4) | 230 (39.5) |
| Secondary | 235 (20.1) | 113 (19.2) | 122 (21.0) |
| College | 434 (37.1) | 215 (36.6) | 219 (37.6) |
| Missing data | 45 (3.8) | 34 (5.8) | 11 (1.9) |
|
| |||
| Patient already had PSA testing, n (%) | 709 (60.6) | 353 (60.0) | 356 (61.2) |
|
| |||
| Family history of prostate cancer, n (%) | 113 (9.7) | 52 (8.8) | 61 (10.5) |
|
| |||
| Patients’ intent to undertake prostate cancer screening prior to intervention, n (%) | |||
| Yes | 878 (75.0) | 446 (75.8) | 432 (74.2) |
| No | 113 (9.7) | 56 (9.5) | 57 (9.8) |
| I don’t know | 174 (14.9) | 85 (14.5) | 89 (14.6 15.3) |
| Missing data | 5 (0.4) | 1(0.2) | 4 (0.6 0.7) |
PSA = prostate-specific antigen. SD = standard deviation.